Kairos PharmaKAPA
13F holders, Q1 2025 (March 31)8holders +3
5new positions
2sold out
1famous investor
$0.93avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Kairos Pharma Ltd. (KAPA) in their 13F filings, up 3 from Q4 2024. 5 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($1.3M), Scientech Research LLC ($45K) and Aptus Capital Advisors, LLC ($41K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kairos Pharma Ltd.
- CUSIP
- 48301N104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.4M |
| Exits | 2 | $585K |
All 13F filers, Q4 2024 → Q1 2025: 1,563,472 shares bought and 392,824 shares sold, net +1,170,648 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Armistice Capital, LLC | 0.04% | New | 1,404,000 | $1.3M |
| Scientech Research LLC | 0.01% | New | 48,198 | $45K |
| Aptus Capital Advisors, LLC | 0.00% | New | 44,286 | $41K |
| SevenBridge Financial Group, LLC | 0.01% | New | 44,286 | $28K |
| Geode Capital Management, LLC | 0.00% | New | 20,433 | $19K |
| Citadel Advisors | 0.00% | Add +20.6% | 13,230 | $12K |
| UBS Group AG | 0.00% | Reduce -74.3% | 2,792 | $3K |
| Bank of America Corp. | 0.00% | Add +61.5% | 21 | $20 |
"% of holder's portfolio" is KAPA's weight in each manager's 13F, not the share of Kairos Pharma Ltd. the manager owns.